CA2260829A1 - Methodes de diagnostic in vitro de maladies neurodegeneratives et trousses pour la mise en oeuvre de ces methodes - Google Patents

Methodes de diagnostic in vitro de maladies neurodegeneratives et trousses pour la mise en oeuvre de ces methodes Download PDF

Info

Publication number
CA2260829A1
CA2260829A1 CA 2260829 CA2260829A CA2260829A1 CA 2260829 A1 CA2260829 A1 CA 2260829A1 CA 2260829 CA2260829 CA 2260829 CA 2260829 A CA2260829 A CA 2260829A CA 2260829 A1 CA2260829 A1 CA 2260829A1
Authority
CA
Canada
Prior art keywords
formula
derivatives
form corresponds
indicated above
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2260829
Other languages
English (en)
French (fr)
Inventor
Claire Banissi
Marie-Claude Tournaire
Michel Troupel
Denis Barritault
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Valbiofrance Ste
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2260829A1 publication Critical patent/CA2260829A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA 2260829 1996-07-17 1997-07-17 Methodes de diagnostic in vitro de maladies neurodegeneratives et trousses pour la mise en oeuvre de ces methodes Abandoned CA2260829A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR96/08941 1996-07-17
FR9608941A FR2751412B3 (fr) 1996-07-17 1996-07-17 Methodes de diagnostic in vitro de maladies neurodegeneratives et trousses pour la mise en oeuvre de ces methodes

Publications (1)

Publication Number Publication Date
CA2260829A1 true CA2260829A1 (fr) 1998-01-29

Family

ID=9494143

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2260829 Abandoned CA2260829A1 (fr) 1996-07-17 1997-07-17 Methodes de diagnostic in vitro de maladies neurodegeneratives et trousses pour la mise en oeuvre de ces methodes

Country Status (6)

Country Link
EP (1) EP0912893A1 (ja)
JP (1) JP2000517048A (ja)
AU (1) AU3773997A (ja)
CA (1) CA2260829A1 (ja)
FR (1) FR2751412B3 (ja)
WO (1) WO1998003869A1 (ja)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234814A (en) * 1989-06-01 1993-08-10 Du Pont Merck Pharmaceutical Company Diagnostic assay for alzheimer's disease
CZ289756B6 (cs) * 1991-03-28 2002-04-17 Eisai Co., Ltd. Heterocyklicko-cyklické aminové deriváty, meziprodukty postupu přípravy těchto sloučenin, farmaceutický prostředek a pouľití uvedených derivátů
US5656447A (en) * 1993-07-30 1997-08-12 Georgetown University Antibodies specific to quinolinic acid
AU7556994A (en) * 1993-08-13 1995-03-14 Molecular Geriatrics Corporation Methods for the diagnosis of alzheimer's disease

Also Published As

Publication number Publication date
JP2000517048A (ja) 2000-12-19
WO1998003869A1 (fr) 1998-01-29
FR2751412B3 (fr) 1998-09-25
FR2751412A1 (fr) 1998-01-23
AU3773997A (en) 1998-02-10
EP0912893A1 (fr) 1999-05-06

Similar Documents

Publication Publication Date Title
Restrepo-Pérez et al. Label-free detection of post-translational modifications with a nanopore
Ageta et al. UBL3 modification influences protein sorting to small extracellular vesicles
Zubiri et al. Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis
Nekrassova et al. Analytical determination of homocysteine: a review
Zheng et al. A mitochondria-targeting near-infrared fluorescent probe for imaging hypochlorous acid in cells
Díaz-Liñán et al. Dual-template molecularly imprinted paper for the determination of drugs of abuse in saliva samples by direct infusion mass spectrometry
Maráková et al. Simultaneous determination of twelve biogenic amines in human urine as potential biomarkers of inflammatory bowel diseases by capillary electrophoresis–tandem mass spectrometry
US9841401B2 (en) Capillary electrophoresis method for analyzing collagen
FR2509313A1 (fr) Derives de 3-fucosyl-n-acetyl lactosamine, leur preparation et leurs applications biologiques
Olszowy et al. Urine sample preparation for proteomic analysis
Pelosi et al. From radioactive ligands to biosensors: binding methods with olfactory proteins
WO2007010110A2 (fr) Procede de detection des fpca utilisant un agent d'agregation des fpca et un agent de capture des agregats formes
Sánchez-López et al. Recent contributions of capillary electrophoresis to neuroscience
JPS62253399A (ja) 脂質結合性シアル酸の測定法
Chou et al. High performance liquid chromatography with fluorimetric detection for the determination of total homocysteine in human plasma: method and clinical applications
Helena et al. Current applications of capillary electrophoresis‐mass spectrometry for the analysis of biologically important analytes in urine (2017 to mid‐2021): A review
Cheng et al. Identification of the Al-binding proteins that account for aluminum neurotoxicity and transport in vivo
Cao et al. Deep learning-assisted single-molecule detection of protein post-translational modifications with a biological nanopore
CH644455A5 (fr) Procede d'analyse quantitative des nucleotides cycliques et ensemble de reactifs pour la mise en oeuvre de ce procede.
Bootorabi et al. Modification of carbonic anhydrase II with acetaldehyde, the first metabolite of ethanol, leads to decreased enzyme activity
CA2260829A1 (fr) Methodes de diagnostic in vitro de maladies neurodegeneratives et trousses pour la mise en oeuvre de ces methodes
Govorun et al. Proteomics and peptidomics in fundamental and applied medical studies
US20230341420A1 (en) Gold nonoclusters, dopamine biosensors including them, and methods for diagnosing neurological diseases using the same
Schweda et al. Profiling LPS glycoforms of non-typeable Haemophilus influenzae by multiple-stage tandem mass spectrometry
Piperevski et al. Determination of total phenols, anthocyanins and color parameters of Vranec wines

Legal Events

Date Code Title Description
FZDE Dead